ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cancer vaccine shows promise in glioblastoma trial
June 11, 2021Personalised cancer vaccine increases progression free survival by approximately 50 percent in patients with newly diagnosed glioblastoma. -
AIVITA Completes Phase 1 Study of Personalized COVID-19 Vaccine Candidate
March 02, 2021AIVITA Biomedical announced the completion of a Phase 1 clinical study in Indonesia of its personalized vaccine candidate, AV-COVID-19, for the novel coronavirus (SARS-CoV-2). -
AIVITA Biomedical's Glioblastoma Trial Shows Improved Progression Free Survival
December 02, 2020AIVITA Biomedical announced data from its multi-center Phase 2 clinical trial of its personalized cancer vaccine, AV-GBM-1, in patients with newly diagnosed glioblastoma (GBM). -
AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial
February 26, 2019AIVITA Biomedical announced its first patient has completed treatment in its multi-center Phase 2 ROOT OF CANCER ovarian cancer trial..... -
AIVITA Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial
November 20, 2018AIVITA Biomedical has dosed the first two patients in its Phase 2 clinical trial in patients with newly diagnosed gliobl
Pharma Sources Insight January 2025
